The relationship between the metabolic syndrome defined by various criteria and the extent of coronary artery disease

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 944-950

  Kasai, Takatoshi ^a   Miyauchi, Katsumi ^a   Kubota, Naozumi ^a   Tamura, Hiroshi ^a   Kojima, Takahiko ^a   Yokoyama, Ken ^a   Kurata, Takeshi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

American Heart Association National Heart; Coronary artery disease; Gensini score; International Diabetes Federation (IDF); Japanese; Lung, and Blood Institute (AHA NHLBI); Metabolic syndrome; National Cholesterol Educational Program Adult Treatment Panel III (NCEP ATPIII)

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL ANALYSIS; UNITED STATES;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 40949085297     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.08.023     Document Type: Article

References (22)

1. Alexander C.M. The coming of age of the metabolic syndrome. Diabetes Care 26 (2003) 3180-3181
2. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
3. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
4. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
5. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
6. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
7. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
8. Grundy S.M., Cleeman J.I., Daniels S.R., et al. American Heart Association; National Heart Lung and Blood Institute. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 112 (2005) 2735-2752
9. Definition and the diagnostic standard for metabolic syndrome. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nippon Naika Gakkai Zasshi 2005;94:794-809 [in Japanese].
10. Oda E., and Watanabe K. Japanese criteria of metabolic syndrome. Circ J 70 (2006) 364
11. Tzou W.S., Douglas P.S., Srinivasan S.R., et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 46 (2005) 457-463
12. Ishizaka N., Ishizaka Y., Toda E., et al. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis 181 (2005) 381-388
13. Heng D., Ma S., Lee J.J., et al. Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis 186 (2005) 367-373
14. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51 (1983) 606
15. Grimes D.A., and Schulz K.F. Refining clinical diagnosis with likelihood ratios. Lancet 365 (2005) 1500-1505
16. Skilton M.R., Moulin P., Serusclat A., Nony P., and Bonnet F. A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for se-specific differences. Atherosclerosis 190 (2007) 416-422
17. Ford E.S. Prevalence of the metabolic syndrome defined by the international diabetes Federation among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
18. Zimmet P.Z., Alberti K.G., and Shaw J.E. Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust 183 (2005) 175-176
19. Athyros V.G., Ganotakis E.S., Elisaf M., and Mikhailidis D.P. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 21 (2005) 1157-1159
20. Masugata H., Senda S., Goda F., et al. Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res 29 (2006) 897-903
21. Kasaoka S., Okuda F., Satoh A., et al. Effect of coronary risk factors on coronary angiographic morphology in patients with ischemic heart disease. Jpn Circ J 61 (1997) 390-395
22. Krishnaswami S., Jose V.J., and Joseph G. Lack of correlation between coronary risk factors and CAD severity. Int J Cardiol 47 (1994) 37-43